Search research articles
Contact Us
Filters
Showing results (11-20 of 68) with videos related to
Page
of 7
Sort By:
Journal of Crohn'S & Colitis
|
May 12, 2026
Comparative risk of serious infection in patients with ulcerative colitis treated with JAK inhibitors
Antoine Meyer, Anaïs Bertrand, Antoine Martin, et al.
Digestive Diseases and Sciences
|
July 21, 2023
WallFlex<sup>®</sup> and Evolution<sup>®</sup> Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction
Antoine Meyer, Antoine Martin, Christophe Bellanger, et al.
Plos One
|
January 22, 2021
Drug use for gastrointestinal symptoms during pregnancy: A French nationwide study 2010-2018
Antoine Meyer, Marion Fermaut, Jérôme Drouin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2026
Serious infection in inflammatory bowel diseases patients treated with vedolizumab, ustekinumab, JAK inhibitors, anti-TNF or aminosalicylates
Anaïs Bertrand, Aurélien Amiot, Antoine Martin, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2021
Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010-2018
Antoine Meyer, Jérôme Drouin, Alain Weill, et al.
Alimentary Pharmacology & Therapeutics
|
October 23, 2020
Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018
Antoine Meyer, Jérôme Drouin, Alain Weill, et al.
International Journal of Colorectal Disease
|
January 7, 2021
Colonoscopy in France during the COVID-19 pandemic
Antoine Meyer, Jérôme Drouin, Mahmoud Zureik, et al.
Alimentary Pharmacology & Therapeutics
|
May 23, 2019
The effectiveness and safety of infliximab compared with biosimilar CT-P13, in 3112 patients with ulcerative colitis
Antoine Meyer, Jérémie Rudant, Jérôme Drouin, et al.
Alimentary Pharmacology & Therapeutics
|
August 26, 2020
Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease
Antoine Chupin, Vittorio Perduca, Antoine Meyer, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 2, 2024
Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors
Marine Jeay, Franck Carbonnel, Caroline Robert, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 68) with videos related to
Sort By:
Page
of 7
Journal of Crohn'S & Colitis
|
May 12, 2026
Comparative risk of serious infection in patients with ulcerative colitis treated with JAK inhibitors
Antoine Meyer, Anaïs Bertrand, Antoine Martin, et al.
Digestive Diseases and Sciences
|
July 21, 2023
WallFlex<sup>®</sup> and Evolution<sup>®</sup> Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction
Antoine Meyer, Antoine Martin, Christophe Bellanger, et al.
Plos One
|
January 22, 2021
Drug use for gastrointestinal symptoms during pregnancy: A French nationwide study 2010-2018
Antoine Meyer, Marion Fermaut, Jérôme Drouin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2026
Serious infection in inflammatory bowel diseases patients treated with vedolizumab, ustekinumab, JAK inhibitors, anti-TNF or aminosalicylates
Anaïs Bertrand, Aurélien Amiot, Antoine Martin, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2021
Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010-2018
Antoine Meyer, Jérôme Drouin, Alain Weill, et al.
Alimentary Pharmacology & Therapeutics
|
October 23, 2020
Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018
Antoine Meyer, Jérôme Drouin, Alain Weill, et al.
International Journal of Colorectal Disease
|
January 7, 2021
Colonoscopy in France during the COVID-19 pandemic
Antoine Meyer, Jérôme Drouin, Mahmoud Zureik, et al.
Alimentary Pharmacology & Therapeutics
|
May 23, 2019
The effectiveness and safety of infliximab compared with biosimilar CT-P13, in 3112 patients with ulcerative colitis
Antoine Meyer, Jérémie Rudant, Jérôme Drouin, et al.
Alimentary Pharmacology & Therapeutics
|
August 26, 2020
Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease
Antoine Chupin, Vittorio Perduca, Antoine Meyer, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 2, 2024
Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors
Marine Jeay, Franck Carbonnel, Caroline Robert, et al.
Page
of 7